WASHINGTON — A small study raises more concern about the long-term consequences of brain injuries suffered by thousands of soldiers — suggesting they may be at risk of developing the same degenerative brain disease as some retired football players.
WASHINGTON — Look for a fundamental shift in how scientists hunt ways to ward off the devastation of Alzheimer’s disease — by testing possible therapies in people who don’t yet show many symptoms, before too much of the brain is destroyed.
Amy Lowell’s love song to lilacs appeals to our sentimental side. But who isn’t sentimental about lilacs? Do they not melt our hearts and fill our memories with April’s first bloom and wafting sweet aroma? Don’t they make you think about lemonade and freshly baked cookies on grandma’s porch? For me, lilacs were a constant on my childishly constructed May Altar where my friends and I would light candles and practice devotions.
ATLANTA — A cancer diagnosis often inspires people to exercise and eat healthier. Now the experts say there’s strong evidence that both habits may help prevent the disease from coming back.
HANFORD, Calif. — The discovery of mad cow disease in a dead dairy cow came soon after it arrived at a non-descript building in the heart of California’s dairy country. The finding, announced Tuesday, is the first new case of the disease in the U.S. since 2006 and the fourth ever discovered in the country. The test was performed when the animal was brought to the building, a transfer facility for a processing plant near Hanford.
WASHINGTON — Republican presidential candidate Newt Gingrich wants to create a lunar colony that he says could become a U.S. state. There’s his grand research plan to figure out what makes the human brain tick. And he’s warned about electromagnetic pulse attacks leaving America without electricity.
WASHINGTON — The government on Thursday said it would adopt strict new limits on using chimpanzees in medical research, after a prestigious scientific group recommended that experiments with humans’ closest relative be done only as a last resort.
WASHINGTON — The first drug to treat a rare disorder that causes red blood cells to build up inside bone marrow was cleared Wednesday by the U.S. Food and Drug Administration.